Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.73 SEK
−310.94 M SEK
0.00 SEK
182.57 M
About VICORE PHARMA HOLDING AB
Sector
CEO
Ahmed S. Mousa
Headquarters
Stockholm
Website
Founded
2001
ISIN
SE0007577895
FIGI
BBG00BM6H589
Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of VICO is 7.78 SEK — it has increased by 0.13% in the past 24 hours. Watch VICORE PHARMA HOLDING AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange VICORE PHARMA HOLDING AB stocks are traded under the ticker VICO.
VICO stock has fallen by −4.07% compared to the previous week, the month change is a −11.29% fall, over the last year VICORE PHARMA HOLDING AB has showed a −48.61% decrease.
We've gathered analysts' opinions on VICORE PHARMA HOLDING AB future price: according to them, VICO price has a max estimate of 40.00 SEK and a min estimate of 15.00 SEK. Watch VICO chart and read a more detailed VICORE PHARMA HOLDING AB stock forecast: see what analysts think of VICORE PHARMA HOLDING AB and suggest that you do with its stocks.
VICO reached its all-time high on Dec 28, 2020 with the price of 37.26 SEK, and its all-time low was 4.86 SEK and was reached on Feb 25, 2016. View more price dynamics on VICO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
VICO stock is 2.62% volatile and has beta coefficient of −0.18. Track VICORE PHARMA HOLDING AB stock price on the chart and check out the list of the most volatile stocks — is VICORE PHARMA HOLDING AB there?
Today VICORE PHARMA HOLDING AB has the market capitalization of 1.82 B, it has decreased by −2.63% over the last week.
Yes, you can track VICORE PHARMA HOLDING AB financials in yearly and quarterly reports right on TradingView.
VICORE PHARMA HOLDING AB is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
VICORE PHARMA HOLDING AB revenue for the last quarter amounts to 0.00 SEK, matching the estimated figure, and no changes in revenue are expected for the next quarter.
VICO net income for the last quarter is −59.95 M SEK, while the quarter before that showed −56.33 M SEK of net income which accounts for −6.43% change. Track more VICORE PHARMA HOLDING AB financial stats to get the full picture.
No, VICO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 25.00 employees. See our rating of the largest employees — is VICORE PHARMA HOLDING AB on this list?
Like other stocks, VICO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VICORE PHARMA HOLDING AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VICORE PHARMA HOLDING AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VICORE PHARMA HOLDING AB stock shows the sell signal. See more of VICORE PHARMA HOLDING AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.